Published in J Biol Chem on August 09, 2007
Cellular and molecular mechanisms of bone remodeling. J Biol Chem (2010) 2.39
Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32
Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem (2009) 1.81
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst (2010) 1.74
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome. Blood (2009) 1.70
PTH and PTHrP signaling in osteoblasts. Cell Signal (2009) 1.69
A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res (2009) 1.61
Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proc Natl Acad Sci U S A (2014) 1.18
Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol (2015) 1.15
Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions. Int J Cancer (2008) 1.15
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic. Prog Mol Biol Transl Sci (2010) 1.14
Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest (2011) 1.12
EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem (2011) 1.06
Osteoimmunology: cytokines and the skeletal system. BMB Rep (2008) 1.04
The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem (2013) 1.00
The molecular mechanism behind bone remodelling: a review. Clin Oral Investig (2009) 0.99
Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2. J Immunol (2014) 0.98
Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts. J Cell Biochem (2009) 0.96
Dendritic cell responses to surface properties of clinical titanium surfaces. Acta Biomater (2010) 0.94
Bone disease in primary hyperparathyrodism. Ther Adv Musculoskelet Dis (2012) 0.89
The role of TLR and chemokine in wear particle-induced aseptic loosening. J Biomed Biotechnol (2012) 0.82
Modulation of Osteoblastic Cell Efferocytosis by Bone Marrow Macrophages. J Cell Biochem (2016) 0.82
PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells. Clin Oral Investig (2010) 0.82
Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts. Calcif Tissue Int (2011) 0.82
Repetition of continuous PTH treatments followed by periodic withdrawals exerts anabolic effects on rat bone. J Bone Miner Metab (2010) 0.81
Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-α in combination with TGF-β in rats. PLoS One (2012) 0.80
Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering. Tissue Eng Part A (2013) 0.79
Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone. J Bone Miner Res (2013) 0.79
The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity. J Clin Endocrinol Metab (2011) 0.78
Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice. PLoS One (2015) 0.77
Osteoblast-osteoclast interactions. Connect Tissue Res (2017) 0.77
Hyperparathyroidism of Renal Disease. Perm J (2016) 0.76
CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone. Front Endocrinol (Lausanne) (2017) 0.75
Bone disease in newly diagnosed lupus nephritis patients. PLoS One (2014) 0.75
Oxysterols and EBI2 promote osteoclast precursor migration to bone surfaces and regulate bone mass homeostasis. J Exp Med (2015) 0.75
Macrophages and skeletal health. Pharmacol Ther (2017) 0.75
The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism. PLoS One (2015) 0.75
Parathyroid Hormone (1-34) Transiently Protects Against Radiation-Induced Bone Fragility. Calcif Tissue Int (2016) 0.75
CCL11, a novel mediator of inflammatory bone resorption. Sci Rep (2017) 0.75
Cytokine, Chemokine, and Growth Factor Profile Characterization of Undifferentiated and Osteoinduced Human Adipose-Derived Stem Cells. Stem Cells Int (2017) 0.75
Strontium-Substituted Bioceramics Particles: A New Way to Modulate MCP-1 and Gro-α Production by Human Primary Osteoblastic Cells. Materials (Basel) (2016) 0.75
The domestication process and domestication rate in rice: spikelet bases from the Lower Yangtze. Science (2009) 3.98
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med (2012) 2.53
Cellular and molecular mechanisms of bone remodeling. J Biol Chem (2010) 2.39
PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest (2006) 2.11
Rapid skeletal turnover in a radiographic mimic of osteopetrosis. J Bone Miner Res (2014) 2.00
Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol Metab (2004) 1.95
Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem (2007) 1.79
Convergent evolution and parallelism in plant domestication revealed by an expanding archaeological record. Proc Natl Acad Sci U S A (2014) 1.73
Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand. J Bone Miner Res (2011) 1.71
Adenosine-stress dynamic myocardial perfusion imaging with second-generation dual-source CT: comparison with conventional catheter coronary angiography and SPECT nuclear myocardial perfusion imaging. AJR Am J Roentgenol (2012) 1.67
Abscisic acid plays an important role in the regulation of strawberry fruit ripening. Plant Physiol (2011) 1.66
Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J Cell Biol (2003) 1.65
M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest (2005) 1.64
Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene (2002) 1.62
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol (2006) 1.58
Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem (2001) 1.57
Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem (2003) 1.53
Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res (2010) 1.52
Low-dose X-irradiation promotes mineralization of fracture callus in a rat model. Arch Orthop Trauma Surg (2008) 1.52
Transcription regulation of ompF and ompC by a single transcription factor, OmpR. J Biol Chem (2006) 1.47
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother (2009) 1.46
Six new metal-organic frameworks based on polycarboxylate acids and V-shaped imidazole-based synthon: syntheses, crystal structures, and properties. Inorg Chem (2011) 1.45
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. J Clin Invest (2012) 1.45
Potential use of erythromycin to prevent and treat prosthetic failure. J Clin Pharmacol (2010) 1.43
Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol (2007) 1.39
High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B. PLoS One (2011) 1.36
A randomized, prospective study of the effects of Tai Chi Chun exercise on bone mineral density in postmenopausal women. Arch Phys Med Rehabil (2004) 1.30
Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. Biomaterials (2006) 1.29
Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model. Bone (2011) 1.26
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest (2005) 1.25
EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem (2007) 1.22
Generalized osteopenia in adolescent idiopathic scoliosis--association with abnormal pubertal growth, bone turnover, and calcium intake? Spine (Phila Pa 1976) (2006) 1.21
Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J Cell Biochem (2006) 1.15
Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J Biol Chem (2004) 1.14
Storage of an excess proton in the hydrogen-bonded network of the d-pathway of cytochrome C oxidase: identification of a protonated water cluster. J Am Chem Soc (2007) 1.14
Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res (2007) 1.13
Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Circulation (2004) 1.13
Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res (2008) 1.12
A secreted SPRY domain-containing protein (SPRYSEC) from the plant-parasitic nematode Globodera rostochiensis interacts with a CC-NB-LRR protein from a susceptible tomato. Mol Plant Microbe Interact (2009) 1.12
Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase. J Biol Chem (2004) 1.12
Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone (2007) 1.11
Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem (2004) 1.11
Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem (2004) 1.10
Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism (2010) 1.10
Effects of BMP-2 and pulsed electromagnetic field (PEMF) on rat primary osteoblastic cell proliferation and gene expression. J Orthop Res (2007) 1.08
High-frequency whole-body vibration improves balancing ability in elderly women. Arch Phys Med Rehabil (2007) 1.08
Mesenchymal progenitors residing close to the bone surface are functionally distinct from those in the central bone marrow. Bone (2012) 1.07
Generalized low bone mass of girls with adolescent idiopathic scoliosis is related to inadequate calcium intake and weight bearing physical activity in peripubertal period. Osteoporos Int (2005) 1.07
EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem (2011) 1.06
Low-magnitude high-frequency vibration accelerates callus formation, mineralization, and fracture healing in rats. J Orthop Res (2009) 1.05
Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice. Proc Natl Acad Sci U S A (2003) 1.05
Reduced bone perfusion in osteoporosis: likely causes in an ovariectomy rat model. Radiology (2010) 1.05
HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression. J Biol Chem (2010) 1.05
The critical role of the epidermal growth factor receptor in endochondral ossification. J Bone Miner Res (2011) 1.04
Gelatin microspheres containing TGF-beta3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. Biomacromolecules (2008) 1.03
Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expression. J Biol Chem (2013) 1.02
Role of the calcium-calpain pathway in cytoskeletal damage after eccentric contractions. J Appl Physiol (1985) (2008) 1.02
Transforming growth factor alpha controls the transition from hypertrophic cartilage to bone during endochondral bone growth. Bone (2012) 1.02
Age-associated decrease of type IIA/B human skeletal muscle fibers. Clin Orthop Relat Res (2006) 1.01
PTH prevents the adverse effects of focal radiation on bone architecture in young rats. Bone (2013) 1.01
Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. Chemistry (2009) 1.01
CD8+ T cells regulate bone tumor burden independent of osteoclast resorption. Cancer Res (2011) 1.00
Association of osteopenia with curve severity in adolescent idiopathic scoliosis: a study of 919 girls. Osteoporos Int (2005) 1.00
Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer. J Exp Med (2013) 0.98
Metal compounds for the treatment of parasitic diseases. J Inorg Biochem (2008) 0.98
Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS One (2012) 0.98
Damaging fatigue loading stimulates increases in periosteal vascularity at sites of bone formation in the rat ulna. Calcif Tissue Int (2007) 0.98
SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell. Mol Cell Biochem (2012) 0.98
Experimental animal models of osteonecrosis. Rheumatol Int (2011) 0.98
Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene. Mol Endocrinol (2009) 0.97
pQCT bone strength index may serve as a better predictor than bone mineral density for long bone breaking strength. J Bone Miner Metab (2003) 0.97
Healing of bone-tendon junction in a bone trough: a goat partial patellectomy model. Clin Orthop Relat Res (2003) 0.97
Low-magnitude high-frequency vibration treatment augments fracture healing in ovariectomy-induced osteoporotic bone. Bone (2009) 0.97
Tonal response patterns of primary auditory cortex neurons in alert cats. Brain Res (2002) 0.97
Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo. J Bone Miner Res (2011) 0.97
Crystallographic and online spectral evidence for role of conformational change and conserved water in cytochrome oxidase proton pump. Proc Natl Acad Sci U S A (2011) 0.96
Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair. J Biomed Mater Res A (2006) 0.96
Regulation of collagenase-3 and osteocalcin gene expression by collagen and osteopontin in differentiating MC3T3-E1 cells. J Biol Chem (2002) 0.96
Origin, distribution and 3D-modeling of Gr-EXPB1, an expansin from the potato cyst nematode Globodera rostochiensis. FEBS Lett (2005) 0.96
Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts. J Bone Miner Res (2012) 0.96
Formation of the stoichiometric complex of EnvZ, a histidine kinase, with its response regulator, OmpR. Mol Microbiol (2002) 0.95
A relook into the association of the estrogen receptor [alpha] gene (PvuII, XbaI) and adolescent idiopathic scoliosis: a study of 540 Chinese cases. Spine (Phila Pa 1976) (2006) 0.95
Extracorporeal shock wave therapy in treatment of delayed bone-tendon healing. Am J Sports Med (2007) 0.95
Constitutional flavonoids derived from Epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis not via direct action by themselves on potential cellular targets. PLoS One (2009) 0.95
Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF. J Biol Chem (2010) 0.94
Vav/Phospholipase Cgamma2-mediated control of a neutrophil-dependent murine model of rheumatoid arthritis. Arthritis Rheum (2008) 0.94
Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation. FEBS Lett (2009) 0.94
Regional variations in microstructural properties of vertebral trabeculae with aging. J Bone Miner Metab (2005) 0.93
Parathyroid hormone stimulation of noncanonical Wnt signaling in bone. Ann N Y Acad Sci (2007) 0.93
Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes. PLoS One (2012) 0.93
Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts. Am J Physiol Endocrinol Metab (2004) 0.93